The development will include five new and repurposed buildings, ranging from three to 13 storeys. Allies and Morrison have designed three of these buildings, with Gibson Thornley responsible for the remaining two. They are expected to be completed by 2028. Supported by Barts Health NHS Trust, Queen Mary University of London, the Greater London Authority, and the borough, this project will provide lab-enabled commercial workspaces, educational facilities, and new public spaces. The goal is to establish Whitechapel as a premier life sciences hub, offering adaptable, high-quality spaces for a variety of life sciences and public health organisations – from small start-ups to larger enterprises.
NHSPS said: “The development also sits within the London Hospital Conservation Area and adjacent to several listed buildings characterised by their unique brickwork, fine detailing, decorative features, and high level of craftsmanship, which has been a key inspiration for our proposals. Some of this heritage is revitalised in the plan. The masterplan features all buildings with ground floor public spaces – including community areas, retail, and outreach services. The success of the new plans is underpinned by an inclusive and contextual public realm, connecting with a complex mix of existing communities, businesses, and institutions, while also providing an environment that is green, safe, and climate-resilient.”
The proposed ‘transformation’ of these five vacant sites has been developed over a number of years through extensive engagement with the local community.
Adrian Powell, director of Investment & Development Management at NHSPS, said: “We’re delighted that the Strategic Development Committee has approved our planning application, which will create a new home for life sciences in Whitechapel. The approval of the planning application is the next step in delivering this long-held vision.
“The proposals will regenerate a series of outdated buildings and empty sites around the Royal London Hospital and Queen Mary University, being the catalyst in creating a thriving life science cluster. The development will deliver a range of economic, health, and social benefits for Tower Hamlets, including the creation of thousands of jobs, as well as attracting major investment into the UK’s life science sector.”